US FDA Revises policy RE: Face Shields During COVID-19 Pandemic
FDA has announced that it does not intend to take enforcement action against face shields that do not comply with FDA’s registration and listing, quality system, certain reporting and unique identification requirements (UDI) in the absence of undue risk. As with its other Enforcement Discretion Policies issued to date, FDA provides examples of measures to be taken to mitigate such risk, including recommended labeling.
North America
Oakland, California, USA
Hebron, Kentucky, USA
Elk Grove, Illinois, USA
Alsip, Illinois, USA
Concord, Ontario
Sioux Falls, South Dakota, USA
Chattanooga, Tennessee, USA
Neenah, Wisconsin, USA
Sandy Hook, Connecticut, USA
Toronto, Ontario
Elmira, New York, USA
South Windsor, Connecticut, USA
Rochester, New York, USA
Bala Cynwyd, Pennsylvania, USA
Montebello, California, USA
Mansfield, Texas, USA
Central America
South America
Europe
Oss, Netherlands
Gaia, Portugal
Winterthur, Switzerland
Tarxien, Malta
Asia
Istanbul, Turkey
Osaka, Japan
Shah Alam, Malaysia
Kolkata, India
Kowloon, Hong Kong
Riyadh, Saudi Arabia
KARACHI, Pakistan
Australia
Associations
Hawleyville, Connecticut, USA
Springfield, Massachusetts, USA
Zurich, Switzerland